Company profile
CanaQuest Medical Corp.
OTC: CANQF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Mississauga, ONCIK 0001607679Reports USD
#1 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 28
v0.1 · 5/100 weight · pillars only
↑ return on assets, listing tenure · ↓ market scale, filing timeliness
Methodology →Revenue TTM
$42.1k
Rev growth YoY (TTM)
+106.4%
Net income (FY)
$857.6k
Employees
10
as of 2026-08-31
Market cap
$2.1k
as of 2026-08-31
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Net income$857.6k1.1M CAD2018
Operating income—1.9M CAD2016
Total assets$85.6k110.3k CAD2018
Equity-$649.9k-837.9k CAD2018
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is CanaQuest Medical Corp.’s financial profile?
CanaQuest Medical Corp. earned $857.6k in FY2018 net income.
Peers · Healthcare
Corix Bioscience, Inc.——Southwestern Medical Solutions, Inc.——Longport, Inc.——InterCare DX, Inc.——iBX Group, Inc.——Evelo Biosciences, Inc.——Key facts
CEOPaul Ramsay
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersMississauga, ON
ExchangeOTC: CANQF
Employees10
IPO date2015-09-17
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.